SUBSCRIBE
SUBSCRIBE

Genentech, Inc.

NEWS
Biotech Bay
The Day In Review: Genentech Pays $919 Million For Tanox, Inc.
November 13, 2006
 · 
1 min read
Biotech Beach
Focus On Rituxan From Genentech, Inc.
October 16, 2006
 · 
1 min read
Biotech Bay
The Day In Review: Genentech, Inc. Wins Avastin Approval For Lung Cancer
October 13, 2006
 · 
1 min read
FDA
New Use For Cancer Fighter; Genentech, Inc. Says It Will Cap Price
October 13, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Genentech, Inc. Hits Its Numbers
October 10, 2006
 · 
1 min read
Biotech Bay
The Day In Review: Amgen Gets Approval For Vectibix
September 27, 2006
 · 
1 min read
Biotech Beach
The Week In Review: A Small Gain Is Still A Gain
September 18, 2006
 · 
1 min read
Biotech Bay
The Day In Review: Genentech, Inc. Casts A Pall Over Biotech
September 11, 2006
 · 
1 min read
Biotech Bay
Genentech, Inc. Falls On Avastin Delay
September 11, 2006
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Business
Galena Biopharma Announces Clinical Development Collaboration With Genentech/Roche and The Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) for NeuVax(TM) (E75) Combined With Herceptin(R) (trastuzumab) in Adjuvant Breast Cancer
November 28, 2011
 · 
4 min read
Lone Star Bio
Susan G. Komen for the Cure Statement on FDA’s Decision Removing Genentech’s Avastin from Approved Breast Cancer Drugs
November 18, 2011
 · 
1 min read
Drug Development
FDA Rejects Genentech’s Avastin for Breast Cancer
November 18, 2011
 · 
9 min read
Business
Apple Taps Former Genentech Chief as New Chairman
November 16, 2011
 · 
1 min read
Policy
Genentech Skin Cancer Drug Gets FDA Priority Review
November 9, 2011
 · 
5 min read
Drug Development
Genentech Release: Data Showed ACTEMRA Monotherapy Significantly Improved Signs and Symptoms of Rheumatoid Arthritis
November 7, 2011
 · 
1 min read
Policy
Genentech Sues University of Pennsylvania Over Patent
October 28, 2011
 · 
1 min read
Pfizer Inc., Sanofi (France) and Genentech Feature Prominently in the Oncology Edition of PharmaDeals’ New Publication Series; Essential Deal Trends
October 20, 2011
 · 
3 min read
Drug Development
Genentech’s Phase II Study Showed Ocrelizumab Maintained Significant Reduction in Disease Activity for Multiple Sclerosis Patients for Almost Two Years
October 20, 2011
 · 
1 min read
Biotech Bay
New Label on Genentech’s Avastin Warns of Infertility
October 5, 2011
 · 
1 min read
Load More